نتایج جستجو برای: hemodialysis solutions

تعداد نتایج: 369502  

2012
Paul Komenda Meghan B Gavaghan Susan S Garfield Amy W Poret Manish M Sood

More intensive and/or frequent hemodialysis may provide clinical benefits to patients with end-stage renal disease; however, these dialysis treatments are more convenient to the patients if provided in their homes. Here we created a standardized model, based on a systematic review of available costing literature, to determine the economic viability of providing hemodialysis in the home that arr...

Journal: :Seminars in dialysis 2004
Robert M Lindsay

The London Daily/Nocturnal Hemodialysis Study, a prospective, comparative, nonrandomized study, directly compared outcomes of quotidian (daily) hemodialysis patients with conventional thrice-weekly hemodialysis patients. Patients were assigned to either daily (short-hours) hemodialysis (n = 11) or nocturnal hemodialysis (n = 12) and followed up for 5-36 months; all data were directly compared w...

Journal: :Journal of the American Society of Nephrology : JASN 2012
Gihad E Nesrallah Robert M Lindsay Meaghan S Cuerden Amit X Garg Friedrich Port Peter C Austin Louise M Moist Andreas Pierratos Christopher T Chan Deborah Zimmerman Robert S Lockridge Cécile Couchoud Charles Chazot Norma Ofsthun Adeera Levin Michael Copland Mark Courtney Andrew Steele Philip A McFarlane Denis F Geary Robert P Pauly Paul Komenda Rita S Suri

Patients undergoing conventional maintenance hemodialysis typically receive three sessions per week, each lasting 2.5-5.5 hours. Recently, the use of more intensive hemodialysis (>5.5 hours, three to seven times per week) has increased, but the effects of these regimens on survival are uncertain. We conducted a retrospective cohort study to examine whether intensive hemodialysis associates with...

2016
Elaine Rutherford Mohammed A. Talle Kenneth Mangion Elizabeth Bell Samuli M. Rauhalammi Giles Roditi Christie McComb Aleksandra Radjenovic Paul Welsh Rosemary Woodward Allan D. Struthers Alan G. Jardine Rajan K. Patel Colin Berry Patrick B. Mark

Noninvasive quantification of myocardial fibrosis in end-stage renal disease is challenging. Gadolinium contrast agents previously used for cardiac magnetic resonance imaging (MRI) are contraindicated because of an association with nephrogenic systemic fibrosis. In other populations, increased myocardial native T1 times on cardiac MRI have been shown to be a surrogate marker of myocardial fibro...

Introduction: The prevalence of Chronic Kidney Disease (CKD) reached about 13.4% in 2016. Among available treatment methods, hemodialysis is the most common way used for the treatment of patients with End-Stage Renal Disease (ESRD), the last stage of CKD. On average, these patients refer to hemodialysis centers three times a week. The high patients referral rate indicates the importance of prop...

Background: Prevention of catheter-related infection is of prime importance,. However, because of the risks caused by the leakage of circulating antibiotics and development of resistance to antibiotics, they are replaced by lock solutions. The aim of this study was to evaluate the efficacy and cost- effectiveness of taurolidine-citrate as a hemodialysis catheter lock solution compared to other ...

2012
Mohsen Abbasnezhad Hamid Tayyebi-Khosroshahi Amin Ghanbarpour Afshin Habibzadeh

BACKGROUND Cardiac disease is the main cause of death in hemodialysis patients. In hemodialysis patients cardiovascular complications are great clinical challenge, and function, shape and left ventricle abnormalities are present in 70 - 80 percent of dialysis patients. Changes in heart function occur in hemodialysis period and are effective in patient's prognosis. In this study we aim to evalua...

2012
Isabella Ramos de Oliveira Liberato Edmundo Pessoa de Almeida Lopes Maria Alina Gomes de Mattos Cavalcante Tiago Costa Pinto Izolda Fernades Moura Luiz Loureiro Júnior

OBJECTIVE The present study was designed to analyze the serum levels of aspartate and alanine aminotransferases, gamma-glutamyl transferase, and the hematocrit in patients with chronic kidney disease who were undergoing peritoneal dialysis or hemodialysis. PATIENTS AND METHODS Twenty patients on peritoneal dialysis and 40 on hemodialysis were assessed, and the patients were matched according ...

A Asadinejad A Shakeri-Zadeh, E Kalantar F Farkhondeh M B Shiran, M Barzegar Marvasti M Shahidi N Tabkhi

Background: Hemodialysis is a process of removing waste and excess fluid from blood when kidneys cannot function efficiently. It often involves diverting blood to the filter of the dialysis machin to be cleared of toxic substances. Fouling of pores in dialysis membrane caused by adhesion of plasma protein and other toxins will reduce the efficacy of the filtre.Objective: In This study, the infl...

Journal: :Antimicrobial agents and chemotherapy 2010
José Moltó José Sanz-Moreno Marta Valle Samandhy Cedeño Jordi Bonal Hanane Bouarich Bonaventura Clotet

Little is known about raltegravir removal by hemodialysis in patients with end-stage renal disease (ESRD). We therefore measured raltegravir concentrations in plasma in pre- and postdialyzer blood samples from 2 ESRD HIV-infected patients. The hemodialysis extraction ratio and raltegravir hemodialysis clearance were 5.5% and 9.1 ml/min in patient 1 and 9.5% and 19.1 ml/min in patient 2, respect...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید